skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 11,953  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Cancer remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
Material Type:
Article 		Add to My Research

Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis

Breast cancer (Tokyo, Japan), 2021-11, Vol.28 (6), p.1167-1180 [Peer Reviewed Journal]

The Author(s) 2020 ;ISSN: 1340-6868 ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-020-01148-2

Digital Resources/Online E-Resources

Citations Cited by
2
Current update on malignant epithelial ovarian tumors
Current update on malignant epithelial ovarian tumors
Material Type:
Article 		Add to My Research

Current update on malignant epithelial ovarian tumors

Abdominal radiology (New York), 2021-06, Vol.46 (6), p.2264-2280 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 ;ISSN: 2366-004X ;EISSN: 2366-0058 ;DOI: 10.1007/s00261-021-03081-0

Full text available

Citations Cited by
3
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study
Material Type:
Article 		Add to My Research

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study

Breast cancer research and treatment, 2012-07, Vol.134 (1), p.353-362 [Peer Reviewed Journal]

Springer Science+Business Media, LLC. 2012 ;2015 INIST-CNRS ;COPYRIGHT 2012 Springer ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-012-2021-9 ;PMID: 22434525 ;CODEN: BCTRD6

Full text available

Citations Cited by
4
Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer
Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer
Material Type:
Article 		Add to My Research

Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer

BMC cancer, 2023-08, Vol.23 (1), p.738-738, Article 738 [Peer Reviewed Journal]

2023. BioMed Central Ltd., part of Springer Nature. ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11229-y ;PMID: 37563628

Full text available

Citations Cited by
5
Ovarian Cancer Screening
Ovarian Cancer Screening
Material Type:
Book 		Add to My Research

Ovarian Cancer Screening

https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode ;ISBN: 3038427152 ;ISBN: 9783038427155 ;ISBN: 9780384271 ;DOI: 10.3390/books978-3-03842-715-5

Full text available

Citations Cited by
6
Correction to "Projected estimates of cancer in Canada in 2024"
Correction to "Projected estimates of cancer in Canada in 2024"
Material Type:
Article 		Add to My Research

Correction to "Projected estimates of cancer in Canada in 2024"

Canadian Medical Association journal (CMAJ), 2024-06, Vol.196 (17), p.E731-E731 [Peer Reviewed Journal]

COPYRIGHT 2024 CMA Impact Inc. ;2024 CMA Impact Inc. or its licensors 2024 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.240712

Full text available

Citations Cited by
7
Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines
Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines
Material Type:
Article 		Add to My Research

Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines

BMC cancer, 2019-11, Vol.19 (1), p.1028-1028, Article 1028 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-6211-2 ;PMID: 31676000

Full text available

Citations Cited by
8
Expression of Concern: Minocycline Suppresses Interleukine-6, Its Receptor System and Signaling Pathways and Impairs Migration, Invasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and In Vivo Studies
Expression of Concern: Minocycline Suppresses Interleukine-6, Its Receptor System and Signaling Pathways and Impairs Migration, Invasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and In Vivo Studies
Material Type:
Article 		Add to My Research

Expression of Concern: Minocycline Suppresses Interleukine-6, Its Receptor System and Signaling Pathways and Impairs Migration, Invasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and In Vivo Studies

PloS one, 2024-02, Vol.19 (2), p.e0298444-e0298444 [Peer Reviewed Journal]

COPYRIGHT 2024 Public Library of Science ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0298444 ;PMID: 38306336

Full text available

Citations Cited by
9
Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers
Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers
Material Type:
Article 		Add to My Research

Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers

Breast cancer research and treatment, 2020-07, Vol.182 (2), p.421-428 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2020 ;COPYRIGHT 2020 Springer ;Springer Science+Business Media, LLC, part of Springer Nature 2020. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-020-05699-y ;PMID: 32445176

Full text available

Citations Cited by
10
Diagnostic Performance of ROMA in Epithelial Ovarian Cancer: a Systematic Review
Diagnostic Performance of ROMA in Epithelial Ovarian Cancer: a Systematic Review
Material Type:
Article 		Add to My Research

Diagnostic Performance of ROMA in Epithelial Ovarian Cancer: a Systematic Review

Indian journal of clinical biochemistry, 2022-05, Vol.34 (S1), p.S99 [Peer Reviewed Journal]

COPYRIGHT 2022 Springer ;ISSN: 0970-1915 ;EISSN: 0974-0422

Full text available

Citations Cited by
11
Evaluation of Serum Levels of Adiponectin as Biomarker for Diagnosis of Ovarian Cancer
Evaluation of Serum Levels of Adiponectin as Biomarker for Diagnosis of Ovarian Cancer
Material Type:
Article 		Add to My Research

Evaluation of Serum Levels of Adiponectin as Biomarker for Diagnosis of Ovarian Cancer

Indian journal of clinical biochemistry, 2022-05, Vol.29 (S1), p.S73 [Peer Reviewed Journal]

COPYRIGHT 2022 Springer ;ISSN: 0970-1915 ;EISSN: 0974-0422

Full text available

Citations Cited by
12
Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan
Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan
Material Type:
Article 		Add to My Research

Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan

Breast cancer research and treatment, 2017, Vol.161 (2), p.191-201 [Peer Reviewed Journal]

Springer Science+Business Media New York 2016 ;COPYRIGHT 2017 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, 2017. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-016-4044-0 ;PMID: 27826754 ;CODEN: BCTRD6

Full text available

Citations Cited by
13
Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario
Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario
Material Type:
Article 		Add to My Research

Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario

European journal of medical research, 2024-03, Vol.29 (1), p.187-187 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 0949-2321 ;EISSN: 2047-783X ;DOI: 10.1186/s40001-024-01767-x ;PMID: 38504328

Full text available

Citations Cited by
14
Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry
Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry
Material Type:
Article 		Add to My Research

Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry

Scientific reports, 2020-05, Vol.10 (1), p.7669-7669, Article 7669 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-020-63466-x ;PMID: 32376921

Full text available

Citations Cited by
15
727 HRD scoring with a SNP assay
727 HRD scoring with a SNP assay
Material Type:
Article 		Add to My Research

727 HRD scoring with a SNP assay

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A267-A267 [Peer Reviewed Journal]

IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2021-ESGO.456

Full text available

Citations Cited by
16
How to make ovarian cancer screening work for patients
How to make ovarian cancer screening work for patients
Material Type:
Article 		Add to My Research

How to make ovarian cancer screening work for patients

Nature (London), 2021-12, Vol.600 (7889), p.S53-S53 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-03721-x ;PMID: 34912094

Full text available

Citations Cited by
17
A synergetic effect of BARD1 mutations on tumorigenesis
A synergetic effect of BARD1 mutations on tumorigenesis
Material Type:
Article 		Add to My Research

A synergetic effect of BARD1 mutations on tumorigenesis

Nature communications, 2021-02, Vol.12 (1), p.1243-13, Article 1243 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-21519-3 ;PMID: 33623049

Full text available

Citations Cited by
18
Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives - a review
Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives - a review
Material Type:
Article 		Add to My Research

Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives - a review

Journal of ovarian research, 2019-11, Vol.12 (1), p.103-103, Article 103 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;The Author(s). 2019 ;ISSN: 1757-2215 ;EISSN: 1757-2215 ;DOI: 10.1186/s13048-019-0579-0 ;PMID: 31685032

Full text available

Citations Cited by
19
Cancer Stem Cell Markers—Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian Cancer (HGSOC) Based on The Cancer Genome Atlas Analysis
Cancer Stem Cell Markers—Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian Cancer (HGSOC) Based on The Cancer Genome Atlas Analysis
Material Type:
Article 		Add to My Research

Cancer Stem Cell Markers—Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian Cancer (HGSOC) Based on The Cancer Genome Atlas Analysis

International journal of molecular sciences, 2023-08, Vol.24 (16), p.12746 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms241612746 ;PMID: 37628927

Full text available

Citations Cited by
20
Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants
Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants
Material Type:
Article 		Add to My Research

Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants

Genetics in medicine, 2018-05, Vol.20 (5), p.554-558 [Peer Reviewed Journal]

Copyright Nature Publishing Group May 2018 ;The Author(s) 2018. corrected publication 2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018, corrected publication 2021 ;ISSN: 1098-3600 ;EISSN: 1530-0366 ;DOI: 10.1038/gim.2017.145 ;PMID: 29261187

Full text available

Citations Cited by

Results 1 - 20 of 11,953  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (10,676)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1986  (15)
  2. 1986 To 1995  (82)
  3. 1996 To 2004  (327)
  4. 2005 To 2014  (3,068)
  5. After 2014  (8,477)
  6. More options open sub menu

Subject 

  1. Ovarian Cancer  (11,842)
  2. Science & Technology  (9,965)
  3. Life Sciences & Biomedicine  (7,934)
  4. Humans  (6,304)
  5. Female  (4,946)
  6. Tumors  (4,652)
  7. Oncology  (4,459)
  8. Chemotherapy  (3,554)
  9. Breast Cancer  (3,425)
  10. Cancer Therapies  (2,932)
  11. Health Aspects  (2,842)
  12. Proteins  (2,778)
  13. Patients  (2,442)
  14. Care And Treatment  (2,426)
  15. Genetic Aspects  (2,389)
  16. Gene Expression  (2,374)
  17. Medical Prognosis  (2,331)
  18. Metastasis  (2,299)
  19. Apoptosis  (2,015)
  20. More options open sub menu

Language 

  1. English  (11,905)
  2. Japanese  (1,486)
  3. Chinese  (40)
  4. French  (15)
  5. Norwegian  (14)
  6. Portuguese  (14)
  7. German  (7)
  8. Turkish  (5)
  9. Polish  (2)
  10. Russian  (2)
  11. Ukrainian  (1)
  12. Italian  (1)
  13. Catalan  (1)
  14. Spanish  (1)
  15. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait